ADLDpk.org
  • Home
  • About
    • ADLD Team
    • Fast Facts
    • History
    • A Word From Chairman
    • Area Of Operation
    • Aims And Objectives
    • Services offered
    • Mission
    • Plan of operation
    • Executive council
    • Midterm Progress Report
  • Forum
  • Education & Training
    • Practice Guidelines
    • Clinical Methods
    • CME
    • Drugs
  • Blog
  • Gallery
  • Contact
  • More >>
    • Membership
    • Books
    • Endorsements
    • Projects
    • Carrier Opportunities
    • Pedometer
    • Diabetes Risk Calculator
    • Android App

Key Points From JNC 8 Guidelines for the Management of Hypertension in Adults

1/25/2016

0 Comments

 

Key Points:

• In the general population, pharmacological treatment should be initiated when blood pressure is 150/90 mm Hg or higher in adults 60 years and older, or 140/90 mm Hg or higher in adults younger than 60 years.
• In patients with hypertension and diabetes, pharmacological treatment should be initiated when blood pressure is 140/90 mm Hg or higher, regardless of age.
• Initial anti hypertensive treatment should include a thiazide diuretic, calcium channel blocker, ACE inhibitor, or ARB in the general non black population or a thiazide diuretic or calcium channel blocker in the general black population.
• If the target blood pressure is not reached within one month after initiating therapy, the dosage of the initial medication should be increased, or a second medication should be added.

Discussion:

These guidelines better known as Relaxing the Standards as changes are made to make practice flexible. Hypertension is one of the most important preventable contributors to disease and death in the United States, leading to myocardial infarction, stroke, and renal failure when it is not detected early and treated appropriately. The Eighth Joint National Committee (JNC 8) recently released evidence-based recommendations on treatment thresholds, goals, and medications in the management of hypertension in adults.
In the general population of adults 60 years and older, pharmacologic treatment should be initiated when the systolic pressure is 150 mm Hg or higher, or when the diastolic pressure is 90 mm Hg or higher. Patients should be treated to a target systolic pressure of less than 150 mm Hg and a target diastolic pressure of less than 90 mm Hg. Treatment does not need to be adjusted if it results in a systolic pressure lower than 140 mm Hg, as long as it is not associated with adverse effects on health or quality of life.
In the general population younger than 60 years, pharmacologic treatment should be initiated when the systolic pressure is 140 mm Hg or higher, or when the diastolic pressure is 90 mm Hg or higher. The target systolic pressure in this population is less than 140 mm Hg, and the target diastolic pressure is less than 90 mm Hg.

For persons 18 years or older with chronic kidney disease (CKD) or diabetes mellitus, the treatment threshold and target blood pressures are the same as those for the general population younger than 60 years (i.e., threshold systolic pressure of 140 mm Hg or threshold diastolic pressure of 90 mm Hg; target systolic pressure of less than 140 mm Hg; target diastolic pressure of less than 90 mm Hg). There is no evidence that treating patients with CKD to a lower blood pressure goal slows the progression of the disease. Similarly, there is no evidence from randomized controlled trials showing that treatment to a systolic pressure of less than 140 mm Hg improves health outcomes in adults with diabetes and hypertension.

In the general nonblack population, including those with diabetes, initial anti-hypertensive treatment should include a thiazide diuretic, calcium channel blocker, angiotensin-converting enzyme (ACE) inhibitor, or angiotensin receptor blocker (ARB). In the general black population, including those with diabetes, initial treatment should include a thiazide diuretic or calcium channel blocker. If the target blood pressure is not reached within one month after initiating therapy, the dosage of the initial medication should be increased or a second medication should be added (thiazide diuretic, calcium channel blocker, ACE inhibitor, or ARB; do not combine an ACE inhibitor with an ARB). Blood pressure should be monitored and the treatment regimen adjusted until the target blood pressure is reached. A third drug should be added if necessary; however, if the target blood pressure cannot be achieved using only the drug classes listed above, antihypertensive drugs from other classes can be used (e.g., beta blockers, aldosterone antagonists). Referral to a physician with expertise in treating hypertension may be necessary for patients who do not reach the target blood pressure using these strategies.
Adults with CKD and hypertension should receive an ACE inhibitor or ARB as initial or add-on therapy, based on moderate evidence that these medications improve kidney-related outcomes in these patients.
Guideline source: Eighth Joint National Committee
0 Comments



Leave a Reply.

    Blog Authors:
    Dr. Saleem Qureshi
    Dr. Musarrat Iqbal
    Dr. Usman Javed

    Archives

    January 2022
    April 2021
    March 2021
    December 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    February 2019
    January 2019
    August 2017
    July 2017
    March 2017
    October 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015

    Categories

    All
    ADLD
    Camp Report
    Career
    CDLD
    Clinical Methods
    CME
    Devices
    Diabetes
    Dr Saleem Qureshi
    Dr Suddle
    Dr Usman Javed
    Endorsements
    Imran Abbas
    Insulin Pump
    Medicine
    Motivation
    News
    Photos
    Shoaib Suddle
    Videos
    Zeba Bakhtiar

    RSS Feed

    Picture
    Picture
    Picture
    Picture
    Picture
Powered by Create your own unique website with customizable templates.